CRBU · Categories · Form 4

CRBU - SEC Form 4 insider transactions

Caribou Biosciences Inc. (CRBU) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CRBU

• 103d
  Chief Technology Officer Kelly Timothy P sold $12,020 worth of shares (6,228 units at $1.93), decreasing direct ownership by 8% to 73,125 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 106d
  Chief Technology Officer Kelly Timothy P was granted 45,000 shares and sold $6,168 worth of shares (3,147 units at $1.96), increasing direct ownership by 112% to 79,353 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 106d
  Chief Legal Officer Mcclung Barbara G was granted 45,000 shares and sold $13,598 worth of shares (6,938 units at $1.96), increasing direct ownership by 9% to 481,564 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 106d
  Chief Business Officer Khan Ruhi Ahmad was granted 45,000 shares and sold $13,598 worth of shares (6,938 units at $1.96), increasing direct ownership by 57% to 104,998 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 106d
  Chief Medical Officer Albertson Tina M. was granted 55,000 shares and sold $2,089 worth of shares (1,066 units at $1.96), increasing direct ownership by 370% to 68,523 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Richardson-Heron Dara

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Johnson David Lee

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Sacks Natalie

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Zheng Ran

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Whiting Nancy

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Guggenhime Andrew

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  SEC Form 4 filed by Director Braunstein Scott

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  Chief Financial Officer Ryali Sriram was granted 55,000 shares, increasing direct ownership by 317% to 72,360 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 110d
  President and CEO Haurwitz Rachel E. was granted 151,700 shares, increasing direct ownership by 51% to 447,150 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  President and CEO Haurwitz Rachel E. was granted 136,750 shares, increasing direct ownership by 86% to 295,450 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  Chief Medical Officer Albertson Tina M. was granted 14,589 shares (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  Chief Legal Officer Mcclung Barbara G was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 8% to 443,502 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  Chief Business Officer Khan Ruhi Ahmad was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 103% to 66,936 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  Chief Technology Officer Kelly Timothy P was granted 37,500 shares (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  Chief Scientific Officer Kanner Steven was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 9% to 431,556 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Zheng Ran

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Whiting Nancy

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Sacks Natalie

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Richardson-Heron Dara

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Johnson David Lee

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Guggenhime Andrew

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 474d
  SEC Form 4 filed by Director Braunstein Scott

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 516d
  SEC Form 4 filed by Chief Financial Officer Ryali Sriram

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 565d
  VP of Finance and Controller Fischesser Ryan was granted 25,000 shares, increasing direct ownership by 27% to 118,854 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 659d
  SEC Form 4 filed by Chief Medical Officer Albertson Tina M.

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  O'Byrne Jason was granted 33,000 shares, increasing direct ownership by 126% to 59,224 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  Mcclung Barbara G was granted 33,000 shares, increasing direct ownership by 9% to 409,566 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  Khan Ruhi Ahmad was granted 33,000 shares (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  Haurwitz Rachel E. was granted 118,700 shares, increasing direct ownership by 297% to 158,700 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  Kanner Steven was granted 33,000 shares, increasing direct ownership by 9% to 387,037 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Zheng Ran

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Whiting Nancy

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Sacks Natalie

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Richardson-Heron Dara

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Johnson David Lee

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Guggenhime Andrew

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 839d
  SEC Form 4 filed by Braunstein Scott

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 853d
  Kanner Steven exercised 30,577 shares at a strike of $2.69, increasing direct ownership by 9% to 354,037 units (SEC Form 4)

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 883d
  SEC Form 4 filed by Kelly Timothy P

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1097d
  SEC Form 4 filed by Haurwitz Rachel E.

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1176d
  SEC Form 4 filed by Haurwitz Rachel E.

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Richardson-Heron Dara

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Haurwitz Rachel E.

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Kanner Steven

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Sacks Natalie

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Khan Ruhi Ahmad

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Rizvi Syed Ali-Aamir

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Zheng Ran

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Mcclung Barbara G

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Guggenhime Andrew

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Braunstein Scott

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Whiting Nancy

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by O'Byrne Jason

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1203d
  SEC Form 4 filed by Johnson David Lee

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
• 1237d
  SEC Form 4: Rizvi Syed Ali-Aamir sold $35,506 worth of shares (5,627 units at $6.31), decreasing direct ownership by 9% to 59,373 units to satisfy withholding tax

  4 - Caribou Biosciences, Inc. (0001619856) (Issuer)

Other CRBU categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends